Journal of Bone Oncology

Papers
(The H4-Index of Journal of Bone Oncology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Separation surgery for metastatic epidural spinal cord compression: A qualitative review43
New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma38
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review37
Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis37
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer31
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways27
Targeting ferroptosis in osteosarcoma25
Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature24
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group24
Potential diagnostic value of miRNAs in peripheral blood for osteosarcoma: A meta-analysis23
The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer23
Malignancy in giant cell tumor of bone in the extremities23
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval22
The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone20
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma18
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-38417
Bone cement as a local chemotherapeutic drug delivery carrier in orthopedic oncology: A review17
Neurological outcomes after surgery for spinal metastases in symptomatic patients: Does the type of decompression play a role? A comparison between different strategies in a 10-year experience17
0.019784927368164